Internationally relied upon by medical practitionersfor its unparalleled focus on adverse effects and cutaneousreactions, Litt""s Drug Eruption & ReactionManual is a succinct clinical reference and essential drug-safety tool forpatient care.
This 26th editionhas been comprehensively revised and updatedthroughout to act as a quick reference, and each entry includes:
* Summaries of numbers of reportsand incidence for reactions
* Clinically important and potentially hazardous drug-drug interactions
* Categories of adverse drug reactions, eruptions, and cutaneous reaction patterns
* Essential reference information on prescription and over-the-counterdrugs as well as biologics and supplements
The book contains...
* A to Z listing of the 1500most consulted generic drug and herbal drug profiles, including generic andtrade names pharmaceutical company indications half-life interactions pregnancycategory and categories of adverse reactions/eruptions, with summaries ofnumber of reports or level of incidence of reaction
* Over 31,000 adverse reactions and drug-eruption listings
* Supplements, vaccines, and other biologics
* Descriptions of important reactions
* List of drugs that cause important reactions
* List of main classes of drugs as a quick clinical reference guide
* 26 tables showing the reaction profile for members of a class of drugs (suchas ACE inhibitors or statins), enabling a clinician tosee at a glance whether a reaction is common to all drugs included in thatclass, or to a majority of them, or is known in only a handful_thisinformation can be used as the basis for an informed decision to change drugsinside the same class
* 2 tables showing reported genetic associations with cutaneousadverse drug reactions and recommendations regarding genetic screening toprevent cutaneous adverse drug reactions
* A concordance of synonyms and trade names for ease of cross-reference
Drug profiles: generic names
Descriptions of important reactions
Drugs that cause important reactions
Main classes of drugs
Calcium channel blockers
Disease-modifying antirheumatic drugs (DMARDS)
Epidermal growth factor receptor (EGFR) inhibitors
Non-steroidal anti-inflammatory drugs (NSAIDS)
Proton pump inhibitors (PPI)
Concordance of synonyms and trade names with generic names
Neil Shear, MD, FRCPC, is Head of Dermatology atSunnybrook & Women""s College HealthSciences Centre and Director of the University of Toronto Drug Safety ResearchGroup. He founded theDrug Safety Clinic at Sunnybrook in 1985 and was the foundingchair of the Canadian AdverseDrug Reaction Advisory Committee (CADRAC) of Health Canada.
No hay reseñas de clientes en este momento.
1 025,00 €